MannKind Corporation
Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent

Last updated:

Abstract:

Methods are provided for drying a particle. Specifically, there is provided a spray-dried diketopiperazine-insulin particle formulation having improved aerodynamic performance and in which the active agent is more stabile and efficiently delivered as compared to that of the lyophilized diketopiperazine-insulin formulation. The dry powders have utility as pharmaceutical formulations for pulmonary delivery.

Status:
Grant
Type:

Utility

Filling date:

4 Oct 2018

Issue date:

13 Aug 2019